Summary
-
Figure 26.1 illustrates how the risk assessment would proceed using the methods described in this chapter.
-
Patients with a hip or vertebral fracture almost certainly have a high risk of subsequent fractures and can be treated even if BMD measurements are not available.
-
In patients without an obvious history of fracture , the prevalent vertebral fracture index (PVFI) can help determine when to obtain spine radiographs to look for undiagnosed vertebral fractures.
-
In patients without fractures, the Osteoporosis Self-assessment Tool (OST), the Osteoporosis Self-assessment Tool for Asians (OSTA), and other tools such as the Simple Calculated Osteoporosis Risk Estimation (SCORE) can help determine whether BMD should be measured.
-
After measuring BMD, fracture probability can be calculated to decide whether treatment is warranted.
-
If BMD is not available, consider treatment if body weight is low and the patient is over 65 years of age, or if the patient is classified as high-risk based on one of the other non-BMD risk indices.
-
Patients receiving treatment should have regular follow-up visits to encourage adherence to treatment.
-
Other patients should be re-evaluated at least every two to five years to see whether their fracture status or risk status has changed.
The focus of this chapter is on assessing the risk of osteoporosis and fractures related to skeletal fragility. Thus, the emphasis is on identifying patients with low BMD and those who have already had a fracture and then using this information to estimate the risk of future fractures. An algorithm is provided in Figure 26.1 to assist the reader in deciding when to use each of the tools described below for evaluating patients. Although falls are an important factor in increasing the risk of fractures among patients with osteoporosis, the etiology and interventions to prevent falls are generally independent of skeletal fragility and therefore receive less attention here.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Geusens P, Hochberg MC, van der Voort DJ, et al. (2002) Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc 77: 629–637.
McLellan AR, Gallacher SJ, Fraser M, McQuillian C. (2004) The Fracture Liaison Service: Success of a programme for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int (in press).
Vogt TM, Ross PD, Palermo L, et al. (2000) Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Mayo Clin Proc 75: 888–896.
Further Reading
American College of Rheumatology Task Force on Osteoporosis Guidelines (1996) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 39: 1791–1801.
Bellantonio S, Fortinsky R, Prestwood K (2001) How well are community-living women treated for osteoporosis after hip fracture? J Am Geriatr Soc 49: 1197–1204.
Bauer DC (2000) Osteoporotic fractures: ignorance is bliss? Am J Med 109: 338–339.
Ben Sedrine W, Park H-M, Reginster J-Y, for the Osteoporosis Self-Assessment Tool for Asia (OSTA) Research Group (2001) Korean experience with the OSTA risk index for osteoporosis: a validation study. Arthritis Rheum 44 (supplement): S260.
Ben Sedrine W, Huang Q-R, Reginster J-Y, for the Osteoporosis Self-Assessment Tool for Asia (OSTA) Research Group (2001) Using the OSTA index to identify women at risk of osteoporosis: a validation study in China. Arthritis Rheum 44 (supplement): S258.
Black DM (2001) A proposal to establish comparable diagnostic categories for bone densitometry based on hip fracture risk among Caucasian women over age 65. J Bone Miner Res 16 (supplement 1): S342.
Black D, Cummings S, Karpf D, et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 1535–1541.
Black DM, Steinbuch M, Palermo L, et al. (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12: 519–528.
Cadarette SM, Iaglal SB, Murray TM, et al. (2001) Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry. J Am Med Assoc 286: 57–63.
Campbell AI, Robertson MC, Gardner MM, et al. (1997) Randomised controlled trial of a general practice programme of home based exercise to prevent falls in elderly women. Br Med J 315: 1065–1069.
Cummings S, Black D, Thompson D, et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture intervention trial. J Am Med Assoc 280:2077–2082.
Delmas PD, Fraser M (2000) Strong bones in later life: luxury or necessity? Bull World Health Organ 77: 416–421.
Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA (2000) Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg 82-A: 1063–1070.
Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH (2001) Interventions for preventing falls in elderly people (Cochrane Review). In: The Cochrane Library, Issue 4, Oxford: Update Software.
Gregg EW, Pereira MA, Caspersen CI (2000) Physical activity, falls, and fracture among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc 48: 883–893.
Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 163: 819–822.
Henry MJ, Paseo JA, Nicholson GC, et al. (2000) Prevalence of osteoporosis in Australian women. Geelong Osteoporosis Study. J Clin Densitom 3: 261–268.
Hochberg MC, Ross PD, Thompson D (2001) Risk factors for clinical fracture in postmenopausal women: data from the Fracture Intervention Trial (FIT). Bone 28 (supplement): S191.
Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE (2000) Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109:326–328.
Kanis J, Delmas P, Burckhardt P, et al. (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7: 390–406.
Kanis JA, Iohnell O, Oden A, et al. (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27: 585–590.
Kanis JA, Iohnell O, Oden A, et al. (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669–674.
Khan SA, de Geus C, Holroyd B, Russell AS (2001) Osteoporos is follow-up after wrist fractures following minor trauma. Arch Intern Med 161: 1309–1312.
Klotzbuecher C, Ross P, Landsman P, Abbott TA III, Berger M (2000) Patient s with prior fractures have an increased risk of future fractures: a Summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739.
Koh L, Ben Sedrine W, Torralba T, et al. (2001) A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int 12:699–705.
Koh LKH, Hoon P, Ng DCE, Sundram FX (2001) Applying a simple clinical tool to identify osteoporosis in a cohort of Singapore women. J Bone Miner Res 16 (supplement 1): S396.
Kroger H, Lunt M, Reeve J. et al. (1999) Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European Quantitation of Osteoporosis Study. Calcif Tissue Int 64: 191–199.
Lindsay R, Silverman SL, Cooper C, et al. (2001) Risk of new vertebral fracture in the year following a fracture. J Am Med Assoc 285: 320–323.
Lydick E, Cook K, Turpin J, et al. (1998) Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone mass. Am J Man Care 4: 37–48.
Margolis KL, Ensrud KE, Schreiner PJ, Tabor HK (2000) Body size and risk for clinical fractures in older women. Ann Intern Med 133: 123–127.
National Osteoporosis Foundation (1998) Physician’s Guide to Prevention and Treatment of Osteoporosis. Belle Mead, NJ: Excerpta Medica.
Nevitt M, Ross P, Palermo L, Musliner T, Genant HK, Thompson DE, for the Fracture Intervention Trial Research Group (1999) The association of prevalent vertebral fractures, bone density and alendronate treatment with incident vertebral fractures: the effect of number and spinal location of fractures. Bone 25: 613–619.
Otsuka M, Spencer B, Wasnich RD (2001) E-medicine: a new approach to osteoporosis management. J Musculoskel Med 18: 387.
Presentation-on-demand. Risk assessment tools, www.presentation-on-demand.com/ Fosamax/register.asp
Rea JA, Li J, Blake GM, et al. (2000) Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int 11: 660–668.
Rights and permissions
Copyright information
© 2004 Springer-Verlag London
About this chapter
Cite this chapter
Ross, P.D., Geusens, P. (2004). Future Developments: Risk Assessment. In: Osteoporosis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-0-85729-402-9_26
Download citation
DOI: https://doi.org/10.1007/978-0-85729-402-9_26
Publisher Name: Springer, London
Print ISBN: 978-1-85233-757-5
Online ISBN: 978-0-85729-402-9
eBook Packages: Springer Book Archive